July 4, 2021
2 mins read

EU may deny entry to Covishield jab receivers

In the UK, where AstraZeneca is the prevalent vaccine in use, a share of the population has received the Indian-made jab, manufactured by Serum Institute of India (SII)….reports Asian Lite News

As the European Union (EU) is reopening borders to non-EU tourists especially those who have been fully vaccinated against Covid-19, travellers inoculated with the Indian-made AstraZeneca vaccine, or Covishield, could face problems when entering the bloc, the European Commission suggested on Friday.

While the AstraZeneca vaccine produced in Europe, branded Vaxzevira, has been greenlighted by the European Medicines Agency (EMA), the Indian version Covishield has not even requested for the market authorization, according to Stefan De Keersmaecker, the Commission’s spokesman for health issues, the Xinhua news agency reported.

In the UK, where AstraZeneca is the prevalent vaccine in use, a share of the population has received the Indian-made jab, manufactured by Serum Institute of India (SII).

In total, five million doses were imported from India, but health authorities said they were not called Covishield and considered the same product as those produced in north Wales and Staffordshire, according to the BBC.

“Of course, the Covishield manufacturer is always free to request the authorization of this vaccine, but for the time being, it is not the case,” said Keersmaecker.

EU President Ursula von der Leyen

An EU-wide Digital Covid Certificate officially entered into force on Thursday, allowing people to travel within the EU-plus area without restrictions if they can either prove to have been fully vaccinated with the EMA-approved vaccines, or have tested negative or recovered from the infection.

Meanwhile, EU member states have the right to accept travelers vaccinated with jabs approved by the World Health Organization (WHO), among which is the Covishield. Media reports said only a small number of the 27 member states have announced the acceptance.

In response to concerns that people from the UK may be denied entry when traveling to the EU, Keersmaecker said the European Commission is working to solve the problem.

“In order to assure a coordinated approach here, the Commission is obviously in contact in discussion with the member states to go through these different vaccines and to see which is the best coordinated approach,” said the spokesman.

ALSO READ: Boris Backs India’s Covishield For EU Green Pass



Previous Story

MoS Muraleedharan to visit Guatemala, Jamaica, Bahamas

Next Story

Covaxin 77.8% effective after Phase 3 trials

Latest from -Top News

Vatican Hosts Final Rites for Pope Francis

The Argentine-born pontiff, the first from Latin America, died less than a month after returning home from a prolonged five-week hospitalisation for double pneumonia….reports Asian Lite News In an outpouring of global

US Backs India’s Hunt for Pahalgam Terrorists

Gabbard’s “hunt down” message comes amidst escalating Indian response to the terrorist attack, saying it had clear “cross-border” links to Pakistan….reports Asian Lite News Tulsi Gabbard, Director of National Intelligence (DNI), on

Border Sealed, Hopes on Hold

A Hindu family from Balochistan’s Sibi was reportedly denied entry into India after the closure of border crossing….reports Asian Lite News Pakistan and India’s decision to shut down the Wagah-Attari border crossing

India Praises UAE’s Global AI Benchmark 

Kaustubh Dhavse, Maharashtra CM’s OSD, hailed the UAE’s AI model as a global benchmark driving digital innovation and attracting global talent…reports Asia Lite News Kaustubh Dhavse, Joint Secretary and Officer on Special

India, Saudi Hold Inaugural Army Staff Talks 

A key highlight of the talks was the exploration of collaboration in operational logistics, battlefield management systems, and niche technologies.  The inaugural Army-to-Army Staff Talks (AAST) between the Indian Army and the
Go toTop

Don't Miss

Global Covid caseload tops 281.3 mn

The global coronavirus caseload has topped 281.3 million, while the

Global Covid caseload tops 264.13 mn

The global coronavirus caseload has topped 264.13 million, while the